My Best Coronavirus Stock for 2021

1 min read

I’m going to tell you something that might seem contradictory. Recently (last week, actually), I wrote about the one stock I’d buy if I could only buy one coronavirus vaccine stock. That stock is Johnson & Johnson. Now for the seeming contradiction: My best coronavirus stock pick for 2021 isn’t Johnson & Johnson.

It’s not just that my previous focus was limited to coronavirus vaccine stocks — a more limited group than coronavirus stocks. If I could only buy one stock of any category, I’d go with the safest choice that’s unlikely to lose money. Hence the selection of J&J. But my benchmark for choosing the best stock of any category is to select the one that offers the most attractive overall risk-reward proposition. There’s a significant difference between those two perspectives.

So which stock is my best coronavirus stock for 2021? I like Novavax (NASDAQ: NVAX) because of its compelling risk-reward profile.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Here’s Why General Motors Is the Only EV Stock I’ll Buy

Next Story

Nikola Secures Energy Partner for Hydrogen Production

Latest from Blog